Advent Technologies Holdings, Inc. (ADN)
NASDAQ: ADN · Real-Time Price · USD
4.870
+0.070 (1.46%)
Dec 3, 2024, 12:06 PM EST - Market open
ADN Stock Forecast
Stock Price Forecast
There is currently no analyst price target forecast available for ADN.
Analyst Consensus: n/a
Analyst Ratings
There are currently no analyst ratings available for ADN.
Recommendation Trends
Rating | Apr '23 | May '23 | Jun '23 | Jul '23 | Aug '23 |
---|---|---|---|---|---|
Strong Buy | 1 | 1 | 1 | 1 | 0 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 1 | 1 | 1 | 1 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
Total | 2 | 2 | 2 | 2 | 0 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Jefferies | Jefferies | Strong Buy → Hold Downgrades $120 → $18 | Strong Buy → Hold | Downgrades | $120 → $18 | +269.61% | Aug 17, 2023 |
Credit Suisse | Credit Suisse | Hold Maintains $540 → $510 | Hold | Maintains | $540 → $510 | +10,372.28% | Oct 25, 2022 |
Jefferies | Jefferies | Strong Buy Maintains $336 → $120 | Strong Buy | Maintains | $336 → $120 | +2,364.07% | Jun 16, 2022 |
Jefferies | Jefferies | Strong Buy Initiates $540 | Strong Buy | Initiates | $540 | +10,988.30% | Mar 19, 2021 |
Financial Forecast
Revenue This Year
113.36M
from 4.86M
Increased by 2,232.99%
Revenue Next Year
217.15M
from 113.36M
Increased by 91.56%
EPS This Year
-0.02
from -37.24
EPS Next Year
0.10
from -0.02
Revenue Forecast
Revenue | 2024 | 2025 |
---|---|---|
High | 117.9M | 225.8M |
Avg | 113.4M | 217.2M |
Low | 110.0M | 210.7M |
Revenue Growth
Revenue Growth | 2024 | 2025 |
---|---|---|
High | 2,325.4% | 99.1% |
Avg | 2,233.0% | 91.6% |
Low | 2,163.8% | 85.9% |
EPS Forecast
EPS | 2024 | 2025 |
---|---|---|
High | -0.02 | 0.11 |
Avg | -0.02 | 0.10 |
Low | -0.02 | 0.10 |
EPS Growth
EPS Growth | 2024 | 2025 |
---|---|---|
High | - | - |
Avg | - | - |
Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.